What is the Projected CAGR value of the Acute Myeloid Leukaemia Therapeutics Market?
Acute Myeloid Leukaemia Therapeutics Market is expected to grow at a CAGR of 13.5% during the forecast period 2024-2031
Who are the key players in Acute Myeloid Leukaemia Therapeutics Market ?
Major players are Novartis AG, Teva Pharmaceuticals, Pfizer, Bristol Myer Squibb, Sanofi-Aventis (Genzyme Corporation), F. Hoffmann-La Roche Ltd, Sunesis Pharmaceuticals Inc., Astellas Pharma, Genmab AS and Otsuka Holdings Co Ltd.